82 related articles for article (PubMed ID: 8275620)
21. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
Ding YA; Chou TC; Lin KC
J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
[TBL] [Abstract][Full Text] [Related]
22. Beta-adrenergic receptor alterations in hypertension--physiological and molecular correlates.
Feldman RD
Can J Physiol Pharmacol; 1987 Aug; 65(8):1666-72. PubMed ID: 2825942
[TBL] [Abstract][Full Text] [Related]
23. Salt sensitivity and the blood pressure response to verapamil.
Weinberger MH; Wagner UL; Fineberg NS
Am J Hypertens; 1994 Jun; 7(6):515-9. PubMed ID: 7917149
[TBL] [Abstract][Full Text] [Related]
24. Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.
Scholze J; Grimm E; Herrmann D; Unger T; Kintscher U
Circulation; 2007 Apr; 115(15):1991-8. PubMed ID: 17404163
[TBL] [Abstract][Full Text] [Related]
25. Beta-adrenoceptor responsiveness in hypertension: effects of dietary NaCl intake.
Feldman RD
Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):55S-60S. PubMed ID: 2176530
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
[TBL] [Abstract][Full Text] [Related]
27. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
28. Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
Chrysant SG; Fox AA; Stimpel M
Am J Hypertens; 1995 Apr; 8(4 Pt 1):418-21. PubMed ID: 7619356
[TBL] [Abstract][Full Text] [Related]
29. [Changes in vascular reactivity during the noradrenaline test in patients with hypertension].
Bakhshaliev AB; Gadzhiev RF; Katyshkina NI; Kholodova OE; Ignatov BA; Boĭko ND
Kardiologiia; 1990 Jan; 30(1):22-6. PubMed ID: 1970839
[TBL] [Abstract][Full Text] [Related]
30. [Effectiveness and tolerance of combined verapamil retard and hydrochlorothiazide. Results of a double-blind, randomized study].
von Manteuffel GE; Rakette S; Woll EM; Reinfrank J; Schiemann J
Fortschr Med; 1995 Sep; 113(26):374-8. PubMed ID: 7498858
[TBL] [Abstract][Full Text] [Related]
31. Lipid profile during antihypertensive treatment. The SLIP Study Group. Study on Lipids with Isoptin Press.
Libretti A; Catalano M
Drugs; 1993; 46 Suppl 2():16-23. PubMed ID: 7512469
[TBL] [Abstract][Full Text] [Related]
32. Low sodium intake corrects abnormality in beta-receptor-mediated arterial vasodilation in patients with hypertension: correlation with beta-receptor function in vitro.
Naslund T; Silberstein DJ; Merrell WJ; Nadeau JH; Wood AJ
Clin Pharmacol Ther; 1990 Jul; 48(1):87-95. PubMed ID: 2164458
[TBL] [Abstract][Full Text] [Related]
33. Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertension.
Rosenbaum D; Girerd X
Curr Med Res Opin; 2012 Feb; 28(2):179-86. PubMed ID: 22114906
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular effects of verapamil in essential hypertension.
Städler P; Leonardi L; Riesen W; Ziegler W; Marone C; Beretta-Piccoli C
Clin Pharmacol Ther; 1987 Nov; 42(5):485-92. PubMed ID: 3315389
[TBL] [Abstract][Full Text] [Related]
35. Stress-induced hemodynamic and hemostatic changes in patients with systemic hypertension: effect of verapamil.
Gebara OC; Jimenez AH; McKenna C; Mittleman MA; Xu P; Lipinska I; Muller JE; Tofler GH
Clin Cardiol; 1996 Mar; 19(3):205-11. PubMed ID: 8674257
[TBL] [Abstract][Full Text] [Related]
36. Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial.
Sorof JM; Cargo P; Graepel J; Humphrey D; King E; Rolf C; Cunningham RJ
Pediatr Nephrol; 2002 May; 17(5):345-50. PubMed ID: 12042891
[TBL] [Abstract][Full Text] [Related]
37. Time course alterations in vascular adrenergic responsiveness in the DOCA/NaCl-treated rat.
Katovich MJ; Soltis EE; Iloeje E; Field FP
Pharmacology; 1984; 29(3):173-80. PubMed ID: 6091157
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring.
Pareek AK; Messerli FH; Chandurkar NB; Dharmadhikari SK; Godbole AV; Kshirsagar PP; Agarwal MA; Sharma KH; Mathur SL; Kumbla MM
J Am Coll Cardiol; 2016 Feb; 67(4):379-389. PubMed ID: 26821625
[TBL] [Abstract][Full Text] [Related]
39. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
Papademetriou V; Hainer JW; Sugg J; Munzer D;
Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
[TBL] [Abstract][Full Text] [Related]
40. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
